Medical devices, healthcare technology and the business of care
510(k) clearance · K260521

ClearEVAC Ureteral Aspirating Access Sheath (PUS-100-1040,PUS-100-1050, PUS-100-1240,PUS-100-1250)

Zhuhai Pusen Medical Technology Co., Ltd. · Decision date Apr 6, 2026

FDA DECISIONK260521

What did the FDA decide?

FDA records K260521 as a 510(k) premarket notification, with a decision dated Apr 6, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Gastroenterology, Urology
Decision date
Apr 6, 2026

FDA source record

Regulatory record facts

Identifier
K260521
Regulatory pathway
510(k) premarket notification
Product code
FED
Decision code
SESE
Decision date
Apr 6, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Endoscopic Access Overtube, Gastroenterology-Urology.

Product code
FED
FDA device class
2

FDA decision timeline

  1. K260521 received

    Application receipt date recorded by FDA.

  2. K260521 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code FED

Product / regulatory recordCompanyPathwayDecision dateSource
Yangzhou Fartley Medical Instrument Technology Co., Ltd.510(k) clearanceSep 21, 2026FDA
NEPTUNE MEDICAL INC.510(k) clearanceSep 18, 2026FDA
Zhejiang Chuangxiang Medical Technology Co., Ltd.510(k) clearanceSep 11, 2026FDA
BOSTON SCIENTIFIC CORPORATION510(k) clearanceAug 4, 2026FDA
Calyxo, Inc.510(k) clearanceApr 13, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Zhuhai Pusen Medical Technology Co., Ltd.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Zhuhai

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records